9-33166911-G-A

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_001497.4(B4GALT1):​c.259C>T​(p.Pro87Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000314 in 1,576,632 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

B4GALT1
NM_001497.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.894
Variant links:
Genes affected
B4GALT1 (HGNC:924): (beta-1,4-galactosyltransferase 1) This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. This gene is unique among the beta4GalT genes because it encodes an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing. Two transcripts, which differ only at the 5' end, with approximate lengths of 4.1 kb and 3.9 kb encode the same protein. The longer transcript encodes the type II membrane-bound, trans-Golgi resident protein involved in glycoconjugate biosynthesis. The shorter transcript encodes a protein which is cleaved to form the soluble lactose synthase. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.005222708).
BP6
Variant 9-33166911-G-A is Benign according to our data. Variant chr9-33166911-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 719722.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
B4GALT1NM_001497.4 linkuse as main transcriptc.259C>T p.Pro87Ser missense_variant 1/6 ENST00000379731.5 NP_001488.2 P15291-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
B4GALT1ENST00000379731.5 linkuse as main transcriptc.259C>T p.Pro87Ser missense_variant 1/61 NM_001497.4 ENSP00000369055.4 P15291-1
B4GALT1ENST00000535206.5 linkuse as main transcriptc.259C>T p.Pro87Ser missense_variant 1/31 ENSP00000440341.1 Q86XA6
B4GALT1-AS1ENST00000654325.1 linkuse as main transcriptn.-37G>A upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.00158
AC:
240
AN:
152234
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00564
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000284
AC:
53
AN:
186338
Hom.:
0
AF XY:
0.000233
AC XY:
24
AN XY:
103072
show subpopulations
Gnomad AFR exome
AF:
0.00437
Gnomad AMR exome
AF:
0.000140
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000368
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000122
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000178
AC:
254
AN:
1424282
Hom.:
0
Cov.:
31
AF XY:
0.000177
AC XY:
125
AN XY:
706454
show subpopulations
Gnomad4 AFR exome
AF:
0.00636
Gnomad4 AMR exome
AF:
0.000225
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000120
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000727
Gnomad4 OTH exome
AF:
0.000422
GnomAD4 genome
AF:
0.00158
AC:
241
AN:
152350
Hom.:
1
Cov.:
33
AF XY:
0.00152
AC XY:
113
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.00565
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000303
Hom.:
0
Bravo
AF:
0.00188
ESP6500AA
AF:
0.00376
AC:
16
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000473
AC:
55
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 06, 2023- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJun 07, 2023Variant summary: B4GALT1 c.259C>T (p.Pro87Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00028 in 186338 control chromosomes, with increased frequency in populations of African descent (0.0044 in 10762 control chromosomes). To our knowledge, no occurrence of c.259C>T in individuals affected with B4GALT1-CDG and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. -
B4GALT1-congenital disorder of glycosylation Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsDec 08, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.011
T;T
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.092
N
LIST_S2
Benign
0.69
T;T
M_CAP
Benign
0.036
D
MetaRNN
Benign
0.0052
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
2.0
.;M
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.41
N;N
REVEL
Benign
0.034
Sift
Benign
0.057
T;T
Sift4G
Benign
0.49
T;T
Polyphen
0.22
.;B
Vest4
0.24
MVP
0.67
MPC
0.49
ClinPred
0.022
T
GERP RS
2.9
Varity_R
0.045
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149181384; hg19: chr9-33166909; API